Review



tissues a rb1 mrna expression across tissues  (Human Protein Atlas)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Human Protein Atlas tissues a rb1 mrna expression across tissues
    (A) Lollipop graph of <t>RB1</t> mutations in <t>retinoblastoma</t> (cBioportal). (B) Lollipop graph of RB1 mutations in different cancers (cBioportal; MSK MetTropism dataset). (C) RB1 alterations in different cancers (MSK MetTropism dataset). (D) Expression of RB1 protein across the cancers (UALCAN).
    Tissues A Rb1 Mrna Expression Across Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rb1+expression/across+galnt2+human+tissues/bio_rxiv__2025__09__22__677485-208-6-13
    Average 86 stars, based on 1 article reviews
    tissues a rb1 mrna expression across tissues - by Bioz Stars, 2026-09
    86/100 stars

    Images

    1) Product Images from "RB1 gene mutations and their association with Endometrial Cancer"

    Article Title: RB1 gene mutations and their association with Endometrial Cancer

    Journal: bioRxiv

    doi: 10.1101/2025.09.22.677485

    (A) Lollipop graph of RB1 mutations in retinoblastoma (cBioportal). (B) Lollipop graph of RB1 mutations in different cancers (cBioportal; MSK MetTropism dataset). (C) RB1 alterations in different cancers (MSK MetTropism dataset). (D) Expression of RB1 protein across the cancers (UALCAN).
    Figure Legend Snippet: (A) Lollipop graph of RB1 mutations in retinoblastoma (cBioportal). (B) Lollipop graph of RB1 mutations in different cancers (cBioportal; MSK MetTropism dataset). (C) RB1 alterations in different cancers (MSK MetTropism dataset). (D) Expression of RB1 protein across the cancers (UALCAN).

    Techniques Used: Expressing

    (A) Lollipop graph of RB1 mutations in endometrial cancer (cBioportal). (B) Nucleotide mutations of RB1 in endometrial cancer. (C) Types of RB1 mutations in endometrial cancer. (D) Graph for total mutation count in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (E) Graph of RB1 mutation vs. diagnosis age. (F) RB1 mutations and there occurrence in endometrial cancer.
    Figure Legend Snippet: (A) Lollipop graph of RB1 mutations in endometrial cancer (cBioportal). (B) Nucleotide mutations of RB1 in endometrial cancer. (C) Types of RB1 mutations in endometrial cancer. (D) Graph for total mutation count in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (E) Graph of RB1 mutation vs. diagnosis age. (F) RB1 mutations and there occurrence in endometrial cancer.

    Techniques Used: Mutagenesis, Biomarker Discovery

    (A) Volcano plot of significantly mutated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Positions of the mutation in the chromosomes. (C) Pathway analysis of significantly mutated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (D) The other tumour suppressor genes mutational status in RB1 altered vs. unaltered endometrial cancer patients (cBioportal).
    Figure Legend Snippet: (A) Volcano plot of significantly mutated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Positions of the mutation in the chromosomes. (C) Pathway analysis of significantly mutated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (D) The other tumour suppressor genes mutational status in RB1 altered vs. unaltered endometrial cancer patients (cBioportal).

    Techniques Used: Mutagenesis

    (A) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Pathway analysis of significantly downregulated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (C) Pathway analysis of significantly upregulated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (D) Pie chart of differentially expressed mutated genes. (C) Bar graph of upregulated genes mutated involved in different pathways.
    Figure Legend Snippet: (A) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Pathway analysis of significantly downregulated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (C) Pathway analysis of significantly upregulated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (D) Pie chart of differentially expressed mutated genes. (C) Bar graph of upregulated genes mutated involved in different pathways.

    Techniques Used:

    (A) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Other tumour suppressor gene’s status in RB1 altered vs. unaltered in another endometrial cancer patients (cBioportal). (C) Nucleotide mutations of RB1 in another endometrial cancer dataset. (D) Types of RB1 mutations in another endometrial cancer dataset. (E) Graph for total mutation count in RB1 altered vs. unaltered another endometrial cancer patients (cBioportal). (F) Graph of RB1 mutation vs. diagnosis age validation. (G) Lollipop graph of RB1 mutations in ovarian cancer (cBioportal). (H) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered ovarian cancer patients (cBioportal). (I) The other tumour suppressor gene mutational status in RB1-altered versus unaltered ovarian cancer patients (cBioportal). (J) Lollipop graph of RB1 mutations in cervical cancer (cBioportal). (K) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered cervical cancer patients (cBioportal). (L) The other tumour suppressor gene mutational status in RB1-altered versus unaltered cervical cancer patients (cBioportal).
    Figure Legend Snippet: (A) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Other tumour suppressor gene’s status in RB1 altered vs. unaltered in another endometrial cancer patients (cBioportal). (C) Nucleotide mutations of RB1 in another endometrial cancer dataset. (D) Types of RB1 mutations in another endometrial cancer dataset. (E) Graph for total mutation count in RB1 altered vs. unaltered another endometrial cancer patients (cBioportal). (F) Graph of RB1 mutation vs. diagnosis age validation. (G) Lollipop graph of RB1 mutations in ovarian cancer (cBioportal). (H) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered ovarian cancer patients (cBioportal). (I) The other tumour suppressor gene mutational status in RB1-altered versus unaltered ovarian cancer patients (cBioportal). (J) Lollipop graph of RB1 mutations in cervical cancer (cBioportal). (K) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered cervical cancer patients (cBioportal). (L) The other tumour suppressor gene mutational status in RB1-altered versus unaltered cervical cancer patients (cBioportal).

    Techniques Used: Mutagenesis, Biomarker Discovery

    Due to mutations in the replication-repair machinery and viral infection (HPV), 14117 other genes were mutated, along with RB1. RB1 and E2F interaction was impaired. 5770 genes involved in cell cycle regulation, cancer-related pathways, and metabolic reprogramming were expressed differentially and regulated the endometrial cancer.
    Figure Legend Snippet: Due to mutations in the replication-repair machinery and viral infection (HPV), 14117 other genes were mutated, along with RB1. RB1 and E2F interaction was impaired. 5770 genes involved in cell cycle regulation, cancer-related pathways, and metabolic reprogramming were expressed differentially and regulated the endometrial cancer.

    Techniques Used: Infection

    Related Articles

    Expressing:

    Article Title: MiR-26a downregulates retinoblastoma in colorectal cancer.
    Article Snippet: .. We found high Rb1 expression levels in 100% of the healthy colon tissues present in The Human Protein Atlas database and, in contrast, in only 60% of cancer tissue. ..



    Similar Products

    cells expressing sgrnas targeting rb1  (InvivoGen)
    99
    InvivoGen cells expressing sgrnas targeting rb1
    Cells Expressing Sgrnas Targeting Rb1, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rb1+expression/Blasticidin/pmc12167974-144-0-11
    Average 99 stars, based on 1 article reviews
    cells expressing sgrnas targeting rb1 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    manuscript n a dual luciferase vector pgl 4 10 hedgehogbio hh luc 043 pcmv3 his rb sino biological hg10137 nh software  (Sino Biological)
    93
    Sino Biological manuscript n a dual luciferase vector pgl 4 10 hedgehogbio hh luc 043 pcmv3 his rb sino biological hg10137 nh software
    Manuscript N A Dual Luciferase Vector Pgl 4 10 Hedgehogbio Hh Luc 043 Pcmv3 His Rb Sino Biological Hg10137 Nh Software, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rb1+expression/Human+RB1%2FOSRC+Gene+ORF+cDNA+clone+expression+plasmid%2C+N-His+tag/pm39970873-238-139-147
    Average 93 stars, based on 1 article reviews
    manuscript n a dual luciferase vector pgl 4 10 hedgehogbio hh luc 043 pcmv3 his rb sino biological hg10137 nh software - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    tissues a rb1 mrna expression across tissues  (Human Protein Atlas)
    86
    Human Protein Atlas tissues a rb1 mrna expression across tissues
    (A) Lollipop graph of <t>RB1</t> mutations in <t>retinoblastoma</t> (cBioportal). (B) Lollipop graph of RB1 mutations in different cancers (cBioportal; MSK MetTropism dataset). (C) RB1 alterations in different cancers (MSK MetTropism dataset). (D) Expression of RB1 protein across the cancers (UALCAN).
    Tissues A Rb1 Mrna Expression Across Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rb1+expression/across+galnt2+human+tissues/bio_rxiv__2025__09__22__677485-208-6-13
    Average 86 stars, based on 1 article reviews
    tissues a rb1 mrna expression across tissues - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    lentiviral vectors expressing tetinducible shrnas against human rb1 construct  (Addgene inc)
    93
    Addgene inc lentiviral vectors expressing tetinducible shrnas against human rb1 construct
    (A) Lollipop graph of <t>RB1</t> mutations in <t>retinoblastoma</t> (cBioportal). (B) Lollipop graph of RB1 mutations in different cancers (cBioportal; MSK MetTropism dataset). (C) RB1 alterations in different cancers (MSK MetTropism dataset). (D) Expression of RB1 protein across the cancers (UALCAN).
    Lentiviral Vectors Expressing Tetinducible Shrnas Against Human Rb1 Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rb1+expression/pSLIK+sh+human+Rb+1534+hyg+(Plasmid+%2331500)/10__7554_slash_elife__93170__3-173-1-79
    Average 93 stars, based on 1 article reviews
    lentiviral vectors expressing tetinducible shrnas against human rb1 construct - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    pcmv3 his rb  (Sino Biological)
    93
    Sino Biological pcmv3 his rb

    Pcmv3 His Rb, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rb1+expression/Human+RB1%2FOSRC+Gene+ORF+cDNA+clone+expression+plasmid%2C+N-His+tag/pmc11866490-560-16-21
    Average 93 stars, based on 1 article reviews
    pcmv3 his rb - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    prk5 ha vector  (Sino Biological)
    93
    Sino Biological prk5 ha vector

    Prk5 Ha Vector, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rb1+expression/Human+RB1%2FOSRC+Gene+ORF+cDNA+clone+expression+plasmid%2C+N-His+tag/pmc11866490-560-14-21
    Average 93 stars, based on 1 article reviews
    prk5 ha vector - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    hg10137 nh  (Sino Biological)
    93
    Sino Biological hg10137 nh

    Hg10137 Nh, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rb1+expression/Human+RB1%2FOSRC+Gene+ORF+cDNA+clone+expression+plasmid%2C+N-His+tag/pmc11866490-162-5-2
    Average 93 stars, based on 1 article reviews
    hg10137 nh - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Lollipop graph of RB1 mutations in retinoblastoma (cBioportal). (B) Lollipop graph of RB1 mutations in different cancers (cBioportal; MSK MetTropism dataset). (C) RB1 alterations in different cancers (MSK MetTropism dataset). (D) Expression of RB1 protein across the cancers (UALCAN).

    Journal: bioRxiv

    Article Title: RB1 gene mutations and their association with Endometrial Cancer

    doi: 10.1101/2025.09.22.677485

    Figure Lengend Snippet: (A) Lollipop graph of RB1 mutations in retinoblastoma (cBioportal). (B) Lollipop graph of RB1 mutations in different cancers (cBioportal; MSK MetTropism dataset). (C) RB1 alterations in different cancers (MSK MetTropism dataset). (D) Expression of RB1 protein across the cancers (UALCAN).

    Article Snippet: Figure S3: RB1 Expressions in normal tissues (A) RB1 mRNA expression across tissues (human protein atlas). (B) RB1 protein expression across tissues (human protein atlas). (C) Protein expression of RB1 in uterine corpus endometrial carcinoma (UALCAN).

    Techniques: Expressing

    (A) Lollipop graph of RB1 mutations in endometrial cancer (cBioportal). (B) Nucleotide mutations of RB1 in endometrial cancer. (C) Types of RB1 mutations in endometrial cancer. (D) Graph for total mutation count in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (E) Graph of RB1 mutation vs. diagnosis age. (F) RB1 mutations and there occurrence in endometrial cancer.

    Journal: bioRxiv

    Article Title: RB1 gene mutations and their association with Endometrial Cancer

    doi: 10.1101/2025.09.22.677485

    Figure Lengend Snippet: (A) Lollipop graph of RB1 mutations in endometrial cancer (cBioportal). (B) Nucleotide mutations of RB1 in endometrial cancer. (C) Types of RB1 mutations in endometrial cancer. (D) Graph for total mutation count in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (E) Graph of RB1 mutation vs. diagnosis age. (F) RB1 mutations and there occurrence in endometrial cancer.

    Article Snippet: Figure S3: RB1 Expressions in normal tissues (A) RB1 mRNA expression across tissues (human protein atlas). (B) RB1 protein expression across tissues (human protein atlas). (C) Protein expression of RB1 in uterine corpus endometrial carcinoma (UALCAN).

    Techniques: Mutagenesis, Biomarker Discovery

    (A) Volcano plot of significantly mutated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Positions of the mutation in the chromosomes. (C) Pathway analysis of significantly mutated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (D) The other tumour suppressor genes mutational status in RB1 altered vs. unaltered endometrial cancer patients (cBioportal).

    Journal: bioRxiv

    Article Title: RB1 gene mutations and their association with Endometrial Cancer

    doi: 10.1101/2025.09.22.677485

    Figure Lengend Snippet: (A) Volcano plot of significantly mutated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Positions of the mutation in the chromosomes. (C) Pathway analysis of significantly mutated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (D) The other tumour suppressor genes mutational status in RB1 altered vs. unaltered endometrial cancer patients (cBioportal).

    Article Snippet: Figure S3: RB1 Expressions in normal tissues (A) RB1 mRNA expression across tissues (human protein atlas). (B) RB1 protein expression across tissues (human protein atlas). (C) Protein expression of RB1 in uterine corpus endometrial carcinoma (UALCAN).

    Techniques: Mutagenesis

    (A) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Pathway analysis of significantly downregulated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (C) Pathway analysis of significantly upregulated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (D) Pie chart of differentially expressed mutated genes. (C) Bar graph of upregulated genes mutated involved in different pathways.

    Journal: bioRxiv

    Article Title: RB1 gene mutations and their association with Endometrial Cancer

    doi: 10.1101/2025.09.22.677485

    Figure Lengend Snippet: (A) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Pathway analysis of significantly downregulated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (C) Pathway analysis of significantly upregulated genes in RB1 altered vs. unaltered endometrial cancer patients (ShinyGO). (D) Pie chart of differentially expressed mutated genes. (C) Bar graph of upregulated genes mutated involved in different pathways.

    Article Snippet: Figure S3: RB1 Expressions in normal tissues (A) RB1 mRNA expression across tissues (human protein atlas). (B) RB1 protein expression across tissues (human protein atlas). (C) Protein expression of RB1 in uterine corpus endometrial carcinoma (UALCAN).

    Techniques:

    (A) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Other tumour suppressor gene’s status in RB1 altered vs. unaltered in another endometrial cancer patients (cBioportal). (C) Nucleotide mutations of RB1 in another endometrial cancer dataset. (D) Types of RB1 mutations in another endometrial cancer dataset. (E) Graph for total mutation count in RB1 altered vs. unaltered another endometrial cancer patients (cBioportal). (F) Graph of RB1 mutation vs. diagnosis age validation. (G) Lollipop graph of RB1 mutations in ovarian cancer (cBioportal). (H) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered ovarian cancer patients (cBioportal). (I) The other tumour suppressor gene mutational status in RB1-altered versus unaltered ovarian cancer patients (cBioportal). (J) Lollipop graph of RB1 mutations in cervical cancer (cBioportal). (K) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered cervical cancer patients (cBioportal). (L) The other tumour suppressor gene mutational status in RB1-altered versus unaltered cervical cancer patients (cBioportal).

    Journal: bioRxiv

    Article Title: RB1 gene mutations and their association with Endometrial Cancer

    doi: 10.1101/2025.09.22.677485

    Figure Lengend Snippet: (A) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered endometrial cancer patients (cBioportal). (B) Other tumour suppressor gene’s status in RB1 altered vs. unaltered in another endometrial cancer patients (cBioportal). (C) Nucleotide mutations of RB1 in another endometrial cancer dataset. (D) Types of RB1 mutations in another endometrial cancer dataset. (E) Graph for total mutation count in RB1 altered vs. unaltered another endometrial cancer patients (cBioportal). (F) Graph of RB1 mutation vs. diagnosis age validation. (G) Lollipop graph of RB1 mutations in ovarian cancer (cBioportal). (H) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered ovarian cancer patients (cBioportal). (I) The other tumour suppressor gene mutational status in RB1-altered versus unaltered ovarian cancer patients (cBioportal). (J) Lollipop graph of RB1 mutations in cervical cancer (cBioportal). (K) Volcano plot of differentially regulated genes in RB1 altered vs. unaltered cervical cancer patients (cBioportal). (L) The other tumour suppressor gene mutational status in RB1-altered versus unaltered cervical cancer patients (cBioportal).

    Article Snippet: Figure S3: RB1 Expressions in normal tissues (A) RB1 mRNA expression across tissues (human protein atlas). (B) RB1 protein expression across tissues (human protein atlas). (C) Protein expression of RB1 in uterine corpus endometrial carcinoma (UALCAN).

    Techniques: Mutagenesis, Biomarker Discovery

    Due to mutations in the replication-repair machinery and viral infection (HPV), 14117 other genes were mutated, along with RB1. RB1 and E2F interaction was impaired. 5770 genes involved in cell cycle regulation, cancer-related pathways, and metabolic reprogramming were expressed differentially and regulated the endometrial cancer.

    Journal: bioRxiv

    Article Title: RB1 gene mutations and their association with Endometrial Cancer

    doi: 10.1101/2025.09.22.677485

    Figure Lengend Snippet: Due to mutations in the replication-repair machinery and viral infection (HPV), 14117 other genes were mutated, along with RB1. RB1 and E2F interaction was impaired. 5770 genes involved in cell cycle regulation, cancer-related pathways, and metabolic reprogramming were expressed differentially and regulated the endometrial cancer.

    Article Snippet: Figure S3: RB1 Expressions in normal tissues (A) RB1 mRNA expression across tissues (human protein atlas). (B) RB1 protein expression across tissues (human protein atlas). (C) Protein expression of RB1 in uterine corpus endometrial carcinoma (UALCAN).

    Techniques: Infection

    Journal: Cell Reports Medicine

    Article Title: KRAS G12D -driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC

    doi: 10.1016/j.xcrm.2025.101966

    Figure Lengend Snippet:

    Article Snippet: In addition, the cDNA sequences of E2F1 and RING1 gene were cloned into the pRK5-HA vector. pCMV3-His-Rb (#HG10137-NH) was purchased from Sino Biological Inc. (Beijing, China). pRK5-HA-Ubi, pRK5- Ring1 , pRK5- UBE2T , deletions-mutant p53 plasmids were constructed in our previous article.

    Techniques: Mutagenesis, Recombinant, Virus, CCK-8 Assay, Membrane, Concentration Assay, Modification, Transfection, Agarose Gel Electrophoresis, Plasmid Preparation, Extraction, Bicinchoninic Acid Protein Assay, Staining, RNA Extraction, H&E Stain, Viability Assay, Reporter Assay, Labeling, Western Blot, Sequencing, Control, Software

    Journal: Cell Reports Medicine

    Article Title: KRAS G12D -driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC

    doi: 10.1016/j.xcrm.2025.101966

    Figure Lengend Snippet:

    Article Snippet: In addition, the cDNA sequences of E2F1 and RING1 gene were cloned into the pRK5-HA vector. pCMV3-His-Rb (#HG10137-NH) was purchased from Sino Biological Inc. (Beijing, China). pRK5-HA-Ubi, pRK5- Ring1 , pRK5- UBE2T , deletions-mutant p53 plasmids were constructed in our previous article.

    Techniques: Mutagenesis, Recombinant, Virus, CCK-8 Assay, Membrane, Concentration Assay, Modification, Transfection, Agarose Gel Electrophoresis, Plasmid Preparation, Extraction, Bicinchoninic Acid Protein Assay, Staining, RNA Extraction, H&E Stain, Viability Assay, Reporter Assay, Labeling, Western Blot, Sequencing, Control, Software

    Journal: Cell Reports Medicine

    Article Title: KRAS G12D -driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC

    doi: 10.1016/j.xcrm.2025.101966

    Figure Lengend Snippet:

    Article Snippet: pCMV3-His-Rb , Sino Biological , HG10137-NH.

    Techniques: Mutagenesis, Recombinant, Virus, CCK-8 Assay, Membrane, Concentration Assay, Modification, Transfection, Agarose Gel Electrophoresis, Plasmid Preparation, Extraction, Bicinchoninic Acid Protein Assay, Staining, RNA Extraction, H&E Stain, Viability Assay, Reporter Assay, Labeling, Western Blot, Sequencing, Control, Software